Yuki Yuza

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 88 publications

Multiomics analysis focusing on genome-wide DNA methylation in paediatric acute promyelocytic leukaemia.

Multiomics analysis focusing on genome-wide DNA methylation in paediatric acute promyelocytic leukaemia.

Journal: British journal of haematology

Published: March 25, 2026

Efficacy of anti-GD2 antibody immunotherapy with filgrastim and teceleukin versus standard treatment with sargramostim, aldesleukin and isotretinoin in children with high-risk neuroblastoma.

Efficacy of anti-GD2 antibody immunotherapy with filgrastim and teceleukin versus standard treatment with sargramostim, aldesleukin and isotretinoin in children with high-risk neuroblastoma.

Journal: International journal of clinical oncology

Published: March 18, 2026

Safety and Efficacy of Tumor-Treating Fields (TTFields) Therapy for Pediatric High-Grade Glioma: Results of a Prespecified Interim Analysis of the First Three Cases.

Safety and Efficacy of Tumor-Treating Fields (TTFields) Therapy for Pediatric High-Grade Glioma: Results of a Prespecified Interim Analysis of the First Three Cases.

Journal: Children (Basel, Switzerland)

Published: December 03, 2025

DTaP-IPV Vaccination-Induced Granuloma Diagnosed With Multi-Virus/Microbial Real-Time PCR.

DTaP-IPV Vaccination-Induced Granuloma Diagnosed With Multi-Virus/Microbial Real-Time PCR.

Journal: Pediatric dermatology

Published: October 07, 2025

Safety and efficacy of arsenic trioxide in intensification therapy for newly diagnosed childhood acute promyelocytic leukemia: results from the JPLSG AML-P13 study.

Safety and efficacy of arsenic trioxide in intensification therapy for newly diagnosed childhood acute promyelocytic leukemia: results from the JPLSG AML-P13 study.

Journal: International journal of hematology

Published: March 28, 2025

A prospective study evaluating the safety and pharmacokinetics of ponatinib at a fixed dose in six paediatric patients with philadelphia chromosome-positive leukaemia: JCCG PedPona19 study.

A prospective study evaluating the safety and pharmacokinetics of ponatinib at a fixed dose in six paediatric patients with philadelphia chromosome-positive leukaemia: JCCG PedPona19 study.

Journal: British journal of haematology

Published: January 13, 2025

Favorable outcomes of de novo advanced phases of pediatric chronic myeloid leukemia in the tyrosine kinase inhibitor era.

Favorable outcomes of de novo advanced phases of pediatric chronic myeloid leukemia in the tyrosine kinase inhibitor era.

Journal: International journal of hematology

Published: December 15, 2024

JCCG ALL-B12: Evaluation of Intensified Therapies With Vincristine/Dexamethasone Pulses and Asparaginase and Augmented High-Dose Methotrexate for Pediatric B-ALL.

JCCG ALL-B12: Evaluation of Intensified Therapies With Vincristine/Dexamethasone Pulses and Asparaginase and Augmented High-Dose Methotrexate for Pediatric B-ALL.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: November 12, 2024

Localized Lymphoblastic Lymphoma in Children and Adolescents: Results of the LLB-NHL03 Trial-A Report From the Japan Children's Cancer Group.

Localized Lymphoblastic Lymphoma in Children and Adolescents: Results of the LLB-NHL03 Trial-A Report From the Japan Children's Cancer Group.

Journal: Pediatric blood & cancer

Published: September 04, 2024

Estimating Number of Nephrons in Living Pediatric Patients Using Nephrectomy Specimens.

Estimating Number of Nephrons in Living Pediatric Patients Using Nephrectomy Specimens.

Journal: Kidney international reports

Published: September 03, 2024

Chemotherapy without anthracyclines for acute promyelocytic leukemia in a 5-year-old male patient with Fontan procedure.

Chemotherapy without anthracyclines for acute promyelocytic leukemia in a 5-year-old male patient with Fontan procedure.

Journal: Pediatrics international : official journal of the Japan Pediatric Society

Published: August 20, 2024

Growth retardation and adult height in pediatric patients with chronic-phase chronic myeloid leukemia treated with tyrosine kinase inhibitors.

Growth retardation and adult height in pediatric patients with chronic-phase chronic myeloid leukemia treated with tyrosine kinase inhibitors.

Journal: Leukemia

Published: August 11, 2024

Showing 1-12 of 88

Last Updated: 09/26/2026